A new study describes the use of artificial intelligence (AI) in designing a new generation of capsids, the structures that envelop genetic material of adeno-associated viruses (AAV), to improve gene ...

Two exciting potential therapies that act like Trojan horses to remove the tau ‘tangles’ that form in Alzheimer’s and other ...

Global AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 621 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.85 % over ...

Research successes are driving gene therapy for inherited deafness to the clinic, but commercialization efforts are needed to ...

AAV Titration and anti-AAV antibody ELISA kits are useful analytical tools in the ongoing advancement of AAV-based gene ...

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...

At Jichi Medical University, in Tochigi, north of Tokyo, much research has focused on establishing the safety and long-term efficacy of AAV vector-mediated gene therapies, including navigating ...

Delve into Vironexis' launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.

Scientists from Spirovant Sciences describe SP-101, a novel adeno-associated virus (AAV) gene therapy for the treatment of ...

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with ...

Previous efforts to circumvent the problem of the size limitation imposed by the AAV vector have focused mainly on altering the candidate genes into ‘mini-expression cassettes’ suitable for ...